臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51833765 線上人數 : 1044 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liao w y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 36-45 / 352 (共36頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-06-27T07:00:01Z	Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum	Liao W.-Y.; Ho C.-C.; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T07:00:01Z	Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients	Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; CHONG-JEN YU; Yang J.C.-H.
臺大學術典藏	2022-06-27T07:00:00Z	Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer	Lee Y.-H.; Liao Y.-C.; Shun S.-C.; Lin K.-C.; Liao W.-Y.; Chang P.-H.; Jhang S.-Y.; CHONG-JEN YU; Yang P.-C.; Hsieh P.-Y.; Lai Y.-H.
臺大學術典藏	2022-06-27T06:59:55Z	Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma	Yang C.-Y.; Hsieh M.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:53Z	Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations	Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:51Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients	Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:49Z	Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors	Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H.
臺大學術典藏	2022-06-27T06:59:47Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:43Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU
臺大學術典藏	2022-06-27T06:59:40Z	Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells	Hou H.-H.; Pan H.-J.; Liao W.-Y.; Lee C.-H.; CHONG-JEN YU

顯示項目 36-45 / 352 (共36頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目